Fernandez Gines, Raquel raquel.fernandezg@uam.es
Publications
- Articles 6
- Books 0
- Book chapters 1
- Conferences 0
- Working papers 0
- Technical reports 0
- Research projects 1
- Supervised theses 0
- Patent or software license 1
Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties
- Herrera-Arozamena, C.
- Estrada-Valencia, M.
- Pérez, C.
- Lagartera, L.
- Morales-García, J.A.
- Pérez-Castillo, A.
- Franco-Gonzalez, J.F.
- Michalska, P.
- Duarte, P.
- León, R.
- López, M.G.
- Mills, A.
- Gago, F.
- García-Yagüe, Á.J.
- Fernández-Ginés, R.
- Cuadrado, A.
- Rodríguez-Franco, M.I.
European Journal Of Medicinal Chemistry - 15/3/2020
Editor: Elsevier Masson s.r.l.
10.1016/j.ejmech.2020.112090 View at source
- ISSN 02235234
- ISSN/ISBN 1768-3254
Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas
- Escoll M
- Lastra D
- Pajares M
- Robledinos-Antón N
- Rojo A
- Fernández-Ginés R
- Mendiola M
- Martínez-Marín V
- Esteban I
- López-Larrubia P
- Gargini R
- Cuadrado A
Redox Biology - 1/2/2020
10.1016/j.redox.2019.101425 View at source
- ISSN 22132317
The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and β-TrCP-NRF2 interactions in cancer chemoresistance
- Srivastava R, Fernández-Ginés R, Encinar JA, Cuadrado A, Wells G
Free Radical Biology And Medicine (p. 246-260) - 1/11/2022
10.1016/j.freeradbiomed.2022.09.023
- ISSN 08915849
- iMarina
Corrigendum to "An inhibitor of interaction between the transcription factor NRF2 and the E3 ubiquitin ligase adapter β-TrCP delivers anti-inflammatory responses in mouse liver" [Redox Biol
- Fernández-Ginés R, Encinar JA, Hayes JD, Oliva B, Rodríguez-Franco MI, Rojo AI, Cuadrado A
Redox Biology (p. 102428-102428) - 1/9/2022
- ISSN 22132317
- iMarina
Can Activation of NRF2 Be a Strategy against COVID-19?
- Cuadrado A
- Pajares M
- Benito C
- Jiménez-Villegas J
- Escoll M
- Fernández-Ginés R
- Garcia Yagüe AJ
- Lastra D
- Manda G
- Rojo AI
- Dinkova-Kostova AT
Trends In Pharmacological Sciences (p. 598-610) - 1/9/2020
10.1016/j.tips.2020.07.003 View at source
- ISSN 01656147
Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development
- Robledinos-Anton, Natalia
- Fernandez-Gines, Raquel
- Manda, Gina
- Cuadrado, Antonio;
Oxidative Medicine And Cellular Longevity - 1/1/2019
10.1155/2019/9372182 View at source
- ISSN 19420900
This researcher has no books.
Perspectives on the Clinical Development of NRF2-Targeting Drugs
- Lastra D
- Fernández-Ginés R
- Manda G
- Cuadrado A
Handbook Of Experimental Pharmacology (p. 93-141) - 1/1/2021
10.1007/164_2020_381 View at source
- ISSN 01712004
This researcher has no conferences.
This researcher has no working papers.
This researcher has no technical reports.
El factor de transcripción nrf2 en la patofisiología de la enfermedad de Alzheimer
- Pajares Cabetas, Marta (Investigador/a)
- GARCIA YAGUE, ANGEL JUAN (Investigador/a)
- FERNANDEZ GINES, RAQUEL (Investigador/a)
- LASTRA MARTINEZ, DIEGO (Investigador/a)
- Cuadrado Pastor, Antonio (Investigador principal (IP))
- Robledinos Anton, Natalia (Investigador/a)
- Escoll Guerrero, Maria Isabel (Investigador/a)
- Rojo Sanchís, Ana Isabel (Investigador principal (IP))
Period: 01-06-2020 - 31-05-2023
Type of funding: National
Amount of funding: 369050,00 Euros.
- iMarina
This researcher has no supervised thesis.
Treatment of NRF2-related diseases
- Cuadrado Pastor, Antonio (Autor o Coautor)
- FERNANDEZ GINES, RAQUEL (Autor o Coautor)
- Leon Martinez, Rafael (Autor o Coautor)
- FRANCO GONZALEZ, JUAN FELIPE (Autor o Coautor)
- Garcia Lopez, Manuela (Autor o Coautor)
- Rojo Sanchís, Ana Isabel (Autor o Coautor)
21/7/2022
- iMarina
Researcher profiles
-
ORCID
-
Scopus Author ID